4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-22-060969
Chief Medical Officer sold 628 shares at $10.87 ($6,826)
- Chief Medical Officer acquired 36,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2022-12-09 | Grant or award | +36,000 | 100,724 | D | ||
| Farwell Wildon Chief Medical Officer | 2022-12-12 | Sale | −628 | $10.87 | $6,826 | 100,096 | D |
| Derivatives | |||||||
| Farwell Wildon Chief Medical Officer | 2022-12-09 | Grant or award · Stock option (right to buy) | +56,000 | 56,000 | D | ||
| Open-market sales · 628 sh · avg $10.87 · $6,826 | |||||||
Loading xslF345X03/doc4.xml…